Matches in Wikidata for { <http://www.wikidata.org/entity/Q66074682> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q66074682 description "assaig clínic" @default.
- Q66074682 description "clinical trial" @default.
- Q66074682 description "clinical trial" @default.
- Q66074682 description "clinical trial" @default.
- Q66074682 description "clinical trial" @default.
- Q66074682 description "ensaio clínico" @default.
- Q66074682 description "ensayo clínico" @default.
- Q66074682 description "ensayu clínicu" @default.
- Q66074682 description "essai clinique" @default.
- Q66074682 description "klinisch onderzoek" @default.
- Q66074682 description "клінічне випробування" @default.
- Q66074682 name "Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma" @default.
- Q66074682 name "Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma" @default.
- Q66074682 type Item @default.
- Q66074682 label "Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma" @default.
- Q66074682 label "Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma" @default.
- Q66074682 prefLabel "Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma" @default.
- Q66074682 prefLabel "Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma" @default.
- Q66074682 P1050 Q66074682-912354DF-A735-4CD4-A82B-B683ECC457C9 @default.
- Q66074682 P1050 Q66074682-91860334-C582-40DD-9EFC-2C99D971382E @default.
- Q66074682 P1132 Q66074682-8C9AA415-1657-4927-9C72-517627B8A12D @default.
- Q66074682 P1476 Q66074682-FA2D636F-5F81-40BF-8049-32ACEC13F004 @default.
- Q66074682 P17 Q66074682-29937D84-1D06-42FF-AE66-63581DB212BC @default.
- Q66074682 P2899 Q66074682-8CF874C9-86F3-4C87-AC50-43EDBF133376 @default.
- Q66074682 P3098 Q66074682-F06D1D4F-5533-4F98-9CC7-510484E4329C @default.
- Q66074682 P31 Q66074682-78E5053C-0883-46BC-8EE0-61985AA0A632 @default.
- Q66074682 P4844 Q66074682-0D123F10-03E3-489D-A2FE-872D3D5ED0C3 @default.
- Q66074682 P4844 Q66074682-1FD4FB89-18D4-4355-8AAE-9C19B30E3520 @default.
- Q66074682 P4844 Q66074682-340E8E4A-C8E1-4315-B3A9-EABA555650C8 @default.
- Q66074682 P4844 Q66074682-3CCCD2DB-8583-4983-A6AF-8E684BA1CE28 @default.
- Q66074682 P4844 Q66074682-52A53D40-6494-4C81-92C4-D213505BC591 @default.
- Q66074682 P4844 Q66074682-6696EA59-637B-4CD0-8CA2-0A2755634A65 @default.
- Q66074682 P4844 Q66074682-6C68D629-848D-4A8F-A4C5-F487BA3CB08D @default.
- Q66074682 P4844 Q66074682-779FF468-4796-465B-AC81-217EF05E99BA @default.
- Q66074682 P4844 Q66074682-B3932449-EE66-49C5-ACC9-E47B95343EE1 @default.
- Q66074682 P4844 Q66074682-BFD0545F-65D1-4E8A-8ECB-EF6517764114 @default.
- Q66074682 P580 Q66074682-AF2B0B07-70A4-46CF-A9DE-34737F054EBE @default.
- Q66074682 P582 Q66074682-6ADC212A-92D9-43B3-9A81-31C38D5507B9 @default.
- Q66074682 P6099 Q66074682-3C7C5156-659C-49C3-A268-7BBB311B08CC @default.
- Q66074682 P6153 Q66074682-E2132D35-E018-4B77-892C-C5B336FA6844 @default.
- Q66074682 P8363 Q66074682-E03A1717-EA47-47FF-A7AA-9F363CEA3864 @default.
- Q66074682 P859 Q66074682-F475E58D-1C0D-42DE-98B6-2B05A204B33F @default.
- Q66074682 P1050 Q208414 @default.
- Q66074682 P1050 Q29496 @default.
- Q66074682 P1132 "+53" @default.
- Q66074682 P1476 "A Phase II Study of Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) as Front-Line Therapy for Adults With Acute Lymphoblastic Leukemia/Lymphoma" @default.
- Q66074682 P17 Q30 @default.
- Q66074682 P2899 "+18" @default.
- Q66074682 P3098 "NCT03023046" @default.
- Q66074682 P31 Q30612 @default.
- Q66074682 P4844 Q18936 @default.
- Q66074682 P4844 Q27260984 @default.
- Q66074682 P4844 Q29004943 @default.
- Q66074682 P4844 Q39045244 @default.
- Q66074682 P4844 Q408524 @default.
- Q66074682 P4844 Q412323 @default.
- Q66074682 P4844 Q419940 @default.
- Q66074682 P4844 Q421193 @default.
- Q66074682 P4844 Q424972 @default.
- Q66074682 P4844 Q50429626 @default.
- Q66074682 P580 "2017-02-23T00:00:00Z" @default.
- Q66074682 P582 "2019-12-01T00:00:00Z" @default.
- Q66074682 P6099 Q42824440 @default.
- Q66074682 P6153 Q219563 @default.
- Q66074682 P8363 Q78089383 @default.
- Q66074682 P859 Q219563 @default.